Cargando…
Developing model biobanking consent language: what matters to prospective participants?
BACKGROUND: Efforts to improve informed consent have led to calls for providing information a reasonable person would want to have, in a way that facilitates understanding of the reasons why one might or might not want to participate. At the same time, advances in large-scale genomic research have e...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227271/ https://www.ncbi.nlm.nih.gov/pubmed/32414333 http://dx.doi.org/10.1186/s12874-020-01001-2 |
_version_ | 1783534469557256192 |
---|---|
author | Beskow, Laura M. Hammack-Aviran, Catherine M. Brelsford, Kathleen M. |
author_facet | Beskow, Laura M. Hammack-Aviran, Catherine M. Brelsford, Kathleen M. |
author_sort | Beskow, Laura M. |
collection | PubMed |
description | BACKGROUND: Efforts to improve informed consent have led to calls for providing information a reasonable person would want to have, in a way that facilitates understanding of the reasons why one might or might not want to participate. At the same time, advances in large-scale genomic research have expanded both the opportunities and the risks for participants, families, and communities. To advance the use of effective consent materials that reflect this landscape, we used empirical data to develop model consent language, as well as brief questions to assist people in thinking about their own values relative to participation. METHODS: We conducted in-person interviews to gather preliminary input on these materials from a diverse sample (n = 32) of the general population in Nashville, Tennessee. We asked them to highlight information they found especially reassuring or concerning, their hypothetical willingness to participate, and their opinions about the values questions. RESULTS: Consent information most often highlighted as reassuring included the purpose of the biobank, the existence and composition of a multidisciplinary oversight committee, the importance of participants’ privacy and efforts to protect it, and controlled access to a scientific database. Information most often highlighted as concerning included the deposition of data in a publicly accessible database, the risk of unintended access to data, the potential for non-research use of data, and use of medical record information in general. Seventy-five percent of participants indicated initial willingness to participate in the hypothetical biobank; this decreased to 66% as participants more closely considered the information over the course of the interview. A large majority rated the values questions as helpful. CONCLUSIONS: These results are consistent with other research on public perspectives on biobanking and genomic cohort studies, suggesting that our model language effectively captures commonly expressed reasons for and against participation. Our study enriches this literature by connecting specific consent form disclosures with qualitative data regarding what participants found especially reassuring or concerning and why. Interventions that facilitate individuals’ closer engagement with consent information may result in participation decisions more closely aligned with their values. |
format | Online Article Text |
id | pubmed-7227271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72272712020-05-27 Developing model biobanking consent language: what matters to prospective participants? Beskow, Laura M. Hammack-Aviran, Catherine M. Brelsford, Kathleen M. BMC Med Res Methodol Research Article BACKGROUND: Efforts to improve informed consent have led to calls for providing information a reasonable person would want to have, in a way that facilitates understanding of the reasons why one might or might not want to participate. At the same time, advances in large-scale genomic research have expanded both the opportunities and the risks for participants, families, and communities. To advance the use of effective consent materials that reflect this landscape, we used empirical data to develop model consent language, as well as brief questions to assist people in thinking about their own values relative to participation. METHODS: We conducted in-person interviews to gather preliminary input on these materials from a diverse sample (n = 32) of the general population in Nashville, Tennessee. We asked them to highlight information they found especially reassuring or concerning, their hypothetical willingness to participate, and their opinions about the values questions. RESULTS: Consent information most often highlighted as reassuring included the purpose of the biobank, the existence and composition of a multidisciplinary oversight committee, the importance of participants’ privacy and efforts to protect it, and controlled access to a scientific database. Information most often highlighted as concerning included the deposition of data in a publicly accessible database, the risk of unintended access to data, the potential for non-research use of data, and use of medical record information in general. Seventy-five percent of participants indicated initial willingness to participate in the hypothetical biobank; this decreased to 66% as participants more closely considered the information over the course of the interview. A large majority rated the values questions as helpful. CONCLUSIONS: These results are consistent with other research on public perspectives on biobanking and genomic cohort studies, suggesting that our model language effectively captures commonly expressed reasons for and against participation. Our study enriches this literature by connecting specific consent form disclosures with qualitative data regarding what participants found especially reassuring or concerning and why. Interventions that facilitate individuals’ closer engagement with consent information may result in participation decisions more closely aligned with their values. BioMed Central 2020-05-15 /pmc/articles/PMC7227271/ /pubmed/32414333 http://dx.doi.org/10.1186/s12874-020-01001-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Beskow, Laura M. Hammack-Aviran, Catherine M. Brelsford, Kathleen M. Developing model biobanking consent language: what matters to prospective participants? |
title | Developing model biobanking consent language: what matters to prospective participants? |
title_full | Developing model biobanking consent language: what matters to prospective participants? |
title_fullStr | Developing model biobanking consent language: what matters to prospective participants? |
title_full_unstemmed | Developing model biobanking consent language: what matters to prospective participants? |
title_short | Developing model biobanking consent language: what matters to prospective participants? |
title_sort | developing model biobanking consent language: what matters to prospective participants? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227271/ https://www.ncbi.nlm.nih.gov/pubmed/32414333 http://dx.doi.org/10.1186/s12874-020-01001-2 |
work_keys_str_mv | AT beskowlauram developingmodelbiobankingconsentlanguagewhatmatterstoprospectiveparticipants AT hammackavirancatherinem developingmodelbiobankingconsentlanguagewhatmatterstoprospectiveparticipants AT brelsfordkathleenm developingmodelbiobankingconsentlanguagewhatmatterstoprospectiveparticipants |